NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)

Active Not RecruitingNA

Sponsor: University of Virginia

Conditions: Huntington Disease, Parkinson Disease

Interventions: MindTrails-Movement, Waitlist Control

Countries: United States

The purpose of this study is to assess preliminary efficacy of a tailored cognitive bias modification for interpretation (CBM-I) app for reducing anxiety in Huntington's disease and Parkinson's disease.

Eligibility overview

Sex: ALL

Age: 21 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Clinical diagnosis of Huntington's disease or Parkinson's disease (genetic diagnosis of HD also acceptable)
* With anxiety symptoms (NeuroQoL Anxiety ≥12)

Exclusion Criteria:

* Cognitive decline precluding ability to consent or complete the intervention (MoCA 5 min/telephone ≤11)
* Unable to read and understand English
* Does not have regular access to an internet-connected device, capable of downloading and installing the mobile application (i.e., tablet or iPhone running iOS 10 or later or an Android phone running Android 5.0 or later)
* Not located in the USA
* \<21 years old
* Active suicidality based on the answer "yes" to questions 4, 5, or 6b of the Columbia-Suicide Severity Rating Scale (Screen version)

Locations (1)

Charlottesville, Virginia, United States